## Most Common Malignant Parotid Tumor **Key Point:** Mucoepidermoid carcinoma (MEC) is the most common malignant tumor of the parotid gland, accounting for approximately 30–40% of all parotid malignancies. **High-Yield:** Mucoepidermoid carcinoma arises from the mucous, serous, and intermediate cells of the salivary gland ducts. It is classified into low-grade, intermediate-grade, and high-grade variants based on histology and clinical behavior. ## Clinical Presentation - **Slow-growing** mass (especially low-grade variants) - **Painless** initially, but may develop pain with higher grades - **Mobile** in early stages; becomes fixed with invasion - Most common in the **parotid gland** (superficial lobe) - Peak incidence: **4th–6th decade** ## Grading & Prognosis | Grade | Features | 5-Year Survival | | --- | --- | --- | | Low-grade | Well-differentiated, slow growth, minimal invasion | 90–95% | | Intermediate | Moderate differentiation, variable behavior | 60–70% | | High-grade | Poorly differentiated, rapid growth, early invasion | 20–40% | **Clinical Pearl:** Low-grade mucoepidermoid carcinomas may be mistaken for benign tumors clinically; histopathology is essential for diagnosis and grade determination. ## Comparison with Other Malignant Parotid Tumors | Tumor | Frequency | Key Feature | | --- | --- | --- | | Mucoepidermoid carcinoma | 30–40% (most common) | Mixed mucous, serous, intermediate cells | | Adenoid cystic carcinoma | 10–15% | Perineural invasion, high recurrence | | Acinic cell carcinoma | 8–10% | Low-grade, serous cells, better prognosis | | Carcinoma ex pleomorphic adenoma | 5–10% | Malignant transformation of benign tumor | **High-Yield:** Adenoid cystic carcinoma, though less common than MEC, has the worst prognosis due to aggressive perineural invasion and high recurrence rates despite treatment.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.